Literature DB >> 16025434

The nitrogen mustard melphalan activates mitogen-activated phosphorylated kinases (MAPK), nuclear factor-kappaB and inflammatory response in lung epithelial cells.

Camilla Osterlund1, Bo Lilliehöök, Barbro Ekstrand-Hammarström, Thomas Sandström, Anders Bucht.   

Abstract

To investigate how respiratory epithelial cells react to an alkylating agent, we exposed human bronchial (BEAS-2B) and alveolar (A549) cells to the nitrogen mustard derivative melphalan. The BEAS-2B cells were highly sensitive to melphalan, as shown by a reduced viability after a 10-min incubation with 300 microM melphalan. The A549 cells were less sensitive and required several hours of exposure to reduce significantly in viability. However, exposure to melphalan also induces activation of intracellular signal transduction pathways, as indicated by phosphorylation of extracellular signal-regulated kinase (ERK1/2) and p38 (proteins belonging to the family of stress-induced mitogen-activated phosphorylated kinases, MAPK) within 5 min, as well as translocation of the transcription factor nuclear factor (NF)-kappaB to the nucleus within 45 min. This early activation was followed by elevated levels of tumor necrosis factor (TNF)-alpha mRNA within 2 h. We also observed increased expression of intercellular adhesion molecule-1 (ICAM-1) on the surface of both cell lines 18 h after exposure to 25 microM melphalan and an increased adhesion of monocytes to the epithelial cells in vitro.In conclusion, we have demonstrated that alkylating compounds not only cause cell death of lung epithelial cells but also activate stress-associated MAPK signal transduction pathways and induce expression of mediators known to participate in the recruitment of inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025434     DOI: 10.1002/jat.1070

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  8 in total

1.  The antibacterial activity of Ga3+ is influenced by ligand complexation as well as the bacterial carbon source.

Authors:  Olena Rzhepishevska; Barbro Ekstrand-Hammarström; Maximilian Popp; Erik Björn; Anders Bucht; Anders Sjöstedt; Henrik Antti; Madeleine Ramstedt
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  Inhibition of NADPH cytochrome P450 reductase by the model sulfur mustard vesicant 2-chloroethyl ethyl sulfide is associated with increased production of reactive oxygen species.

Authors:  Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-02       Impact factor: 4.219

Review 3.  Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity.

Authors:  Barry Weinberger; Jeffrey D Laskin; Vasanthi R Sunil; Patrick J Sinko; Diane E Heck; Debra L Laskin
Journal:  Pulm Pharmacol Ther       Date:  2010-09-17       Impact factor: 3.410

Review 4.  Anti-TNFα therapy in inflammatory lung diseases.

Authors:  Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

5.  Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.

Authors:  Yi-Hua Jan; Diane E Heck; Robert P Casillas; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2015-10-19       Impact factor: 3.739

6.  Macrophage activation in the lung during the progression of nitrogen mustard induced injury is associated with histone modifications and altered miRNA expression.

Authors:  Alessandro Venosa; L Cody Smith; Andrew J Gow; Helmut Zarbl; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2021-05-07       Impact factor: 4.460

7.  Nitrogen mustard hydrochloride-induced acute respiratory failure and myelosuppression: A case report.

Authors:  Xiaojuan Zhang; Zhidan Zhang; Song Chen; Dongmei Zhao; Fangxiao Zhang; Ziwei Hu; Feng Xiao; Xiaochun Ma
Journal:  Exp Ther Med       Date:  2015-07-29       Impact factor: 2.447

Review 8.  Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review.

Authors:  Barbara Kaltschmidt; Kaya E Witte; Johannes F W Greiner; Florian Weissinger; Christian Kaltschmidt
Journal:  Biomedicines       Date:  2022-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.